11.12.2012 Views

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(12) PATENT APPLICATION PUBLICATION (21) Application No.6576/DELNP/2008 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :29/07/2008 (43) Publication Date : 24/10/2008<br />

(54) Title <strong>of</strong> the invention : PROTEASOM OR UPS INHIBITOR FOR TREATING INFECTIONS WITH INFLUENZA VIRUSES<br />

(51) International classification :A61P 31/16 (71)Name <strong>of</strong> Applicant :<br />

(31) Priority Document No<br />

:10 2006 008 321.0-<br />

41<br />

1)VIROLOGIK GMBH<br />

Address <strong>of</strong> Applicant :HENKESTRASSE 91, 91052<br />

(32) Priority Date :17/02/2006 ERLANGEN (DE) Germany<br />

(33) Name <strong>of</strong> priority country :Germany<br />

(72)Name <strong>of</strong> Inventor :<br />

(86) International Application No :PCT/EP2007/051510 1)SCHUBERT, ULRICH<br />

Filing Date<br />

:16/02/2007<br />

2)LUDWIG, STEPHAN<br />

(87) International Publication No :WO 2007/093635 3)PLANZ, OLIVER<br />

(61) Patent <strong>of</strong> Addition to Application<br />

Number<br />

Filing Date<br />

:NA<br />

:NA<br />

(62) Divisional to Application Number :NA<br />

Filing Date<br />

:NA<br />

(57) Abstract :<br />

The invention concerns drugs for prophylaxis <strong>and</strong>/or treatment <strong>of</strong> virus infections, in <strong>part</strong>icular 01 infections with influenza viruses<br />

releasing grippal infectants. The subject <strong>of</strong> the invention are drugs contain as active ingredients inhibitors <strong>of</strong> the ubiquitin-proteasome<br />

system, in <strong>part</strong>icular proteasome inhibitors. The present invention furthermore concerns the systemic as also the topical, preferably<br />

aerogenous, administration <strong>of</strong> proteasome inhibitors. The active ingredient <strong>of</strong> a proteasome inhibitor put to use according to the<br />

invention can be used with at least one further antivirally-active substance for the prophylaxis <strong>and</strong> /or therapy <strong>of</strong> influenza virus<br />

infections.<br />

No. <strong>of</strong> Pages : 46 No. <strong>of</strong> Claims : 25<br />

The Patent Office Journal 24/10/2008 26060

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!